icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria áapril 22-26
Back grey_arrow_rt.gif
 
 
 
Ledipasvir/Sofosbuvir for the Treatment of Patients With
Chronic Genotype 4 or 5 HCV Infection

 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Armand Abergel1, Veronique Loustaud-Ratti2, Sophie Metivier3, Deyuan Jiang4, Kathryn Kersey4, Steven J. Knox4, Evguenia Svarovskaia4, Philip S. Pang4, Didier Samuel5, Tarik Asselah6
1Centre Hospitalier Universitaire-Estaing, Universite d'Auvergne,
Clermont-Ferrand, France; 2Centre Hospitalier Universitaire-Limoges, Inserm UMR 1092, Limoges, France; 3Centre Hospitalier Universitaire-Purpan, Toulouse, France; 4Gilead Sciences, Inc., Foster City, California, USA; 5H˘pital Paul Brousse, Universite Paris Sud, Villejuif, France; 6University Paris Diderot and INSERM U773, Beaujon Hospital, Clichy, France

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif

EASL9.gif